Albany, New York, June 7, 2017: Rising humanization of pets and adoption in developed markets such as the U.S. is driving growth for animal vaccines. Furthermore, rising trend of using pets as a status symbol in various countries is also likely to fuel the market’s growth. A report titled “Companion Animal Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2016–2026” has been recently added to the vast online repository of Market Research Reports Search Engine (MRRSE). The report is an analysis of the current state as well as the future outlook of the global companion animal vaccines market.
The global companion animal vaccines market is expected to rise at a CAGR of 6.8% during the forecast period 2016 – 2026. At this pace, the market is likely to reach a value of nearly US$ 4,500 million by the end of 2026 from US$ 2,100 million in 2015. The report starts with the market definition, followed by definitions of the different companion animal vaccine product types. The report offers insights on the market dynamics that can influence the growth of the global companion animal vaccines market during the forecast period. Insights on major trends, growth drivers, restraints, value forecasts and opportunities for companies in the global companion animal vaccines market are provided in the report.
To understand and evaluate opportunities in this market, the report offers a market forecast on the basis of product type, species type, distribution channel, and region. Based on product type, the markets segments include attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines and recombinant vaccines. On the basis of species type, the global market is segmented into canine, avian and feline. The report offers analysis of the global companion animal vaccines market in terms of market value (million US$). The market dynamics section covers analysis of drivers, restraints, key trends, opportunities and other macroeconomic factors impacting the demand for the companion animal vaccines.
In the final section of the report, a competitive landscape analysis has been covered to provide a dashboard view of major companies operating in the global companion animal vaccines market. This section is mainly designed to provide readers with an objective and in-depth comparative assessment of providers specific to a market segment in the global companion animal vaccines market. Moreover, this section also includes market strategies and SWOT analysis of the leading companies operating in the global companion animal vaccines market. Detailed profiles of companion animal vaccine product vendors are also covered within the scope of the report to evaluate their long- and short-term strategies. Some of the key players include Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Merial (Sanofi), Virbac and Zoetis (Pfizer).
Browse Full Global Companion Animal Vaccines Market Report with TOC : http://www.mrrse.com/companion-animal-vaccines-market-report
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207